Regeneron Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
808.79
|
|
Average Rating
|
3.73
|
|
# Strong Buys
|
8
|
|
# Buys
|
5
|
|
# Holds
|
11
|
|
# Sells
|
2
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
9.48
|
11.14
|
1.66
|
17.51%
|
|
2022-06-30
|
8.84
|
9.77
|
0.93
|
10.52%
|
|
2022-03-31
|
9.74
|
11.49
|
1.75
|
17.97%
|
|
2021-12-31
|
18.35
|
21.32
|
2.97
|
16.19%
|
|
2021-09-30
|
10.10
|
14.33
|
4.23
|
41.88%
|
|
2021-06-30
|
17.53
|
27.97
|
10.44
|
59.56%
|
|
2021-03-31
|
9.00
|
10.09
|
1.09
|
12.11%
|
|
2020-12-31
|
8.39
|
9.53
|
1.14
|
13.59%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
32.40
|
|
2021-12-31
|
73.71
|
|
2020-12-31
|
31.65
|
|
2019-12-31
|
24.64
|
|
2018-12-31
|
22.83
|
|
2017-12-31
|
16.31
|
|
2016-12-31
|
11.56
|
|
2015-12-31
|
12.07
|
|
2014-12-31
|
10.04
|
|
2013-12-31
|
3.80
|
|
2012-12-31
|
3.80
|
|
2011-12-31
|
-2.40
|
|
2010-12-31
|
-1.27
|
|
2009-12-31
|
-0.88
|
|
2008-12-31
|
-1.05
|
|
2007-12-31
|
-1.60
|
|
2006-12-31
|
-1.76
|
|
2005-12-31
|
-1.50
|
|
2004-12-31
|
0.65
|
|
2003-12-31
|
-2.13
|
|
2002-12-31
|
-2.83
|
|
2001-12-31
|
-1.80
|
|
2000-12-31
|
-0.63
|
|
1999-12-31
|
-0.74
|
|
1998-12-31
|
-0.67
|
|
1996-12-31
|
-1.33
|
|
1995-12-31
|
-1.14
|
|
1994-12-31
|
-1.05
|